Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2002 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: ARESTIN

« Back to Dashboard

Summary for Tradename: ARESTIN

Patents:0
Applicants:1
NDAs:1
Suppliers: see list1

Pharmacology for Tradename: ARESTIN

Ingredient-typeTetracyclines
Drug ClassTetracycline-class Drug

Clinical Trials for: ARESTIN

Minocycline for Postsurgical Symptom Reduction in Head and Neck Cancer
Status: Recruiting Condition: Head And Neck Cancer

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy
Status: Recruiting Condition: Lung Cancer

Minocycline Therapy for Management of Adverse Radiation Effects
Status: Not yet recruiting Condition: Irradiation; Adverse Effect

Minocycline and Aspirin in the Treatment of Bipolar Depression
Status: Recruiting Condition: Bipolar Disorder Depression

Study to Evaluate the Efficacy and Safety of Minocycline in Angelman Syndrome
Status: Active, not recruiting Condition: Angelman Syndrome

A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
Status: Active, not recruiting Condition: Esophageal Cancer

Minocycline Study in Pancreatic Cancer Patients
Status: Recruiting Condition: Pancreatic Cancer

Minocycline in Clinically Isolated Syndromes (CIS)
Status: Active, not recruiting Condition: Clinically Isolated Syndromes; Early Single Relapse of Multiple Sclerosis

Minocycline and Proteinuria in Diabetic Nephropathy
Status: Active, not recruiting Condition: Diabetic Nephropathy

A Study for Reducing Symptom Burden Produced by Chemoradiation Treatment for Non Small Cell Lung Cancer by Minocycline and Armodafinil
Status: Active, not recruiting Condition: Lung Cancer

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Orapharma
ARESTIN
minocycline hydrochloride
Powder, Extended Release; Dental050781FEB 16, 2001RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc